Option Fee. In order to exercise the Option under Section 2.2(b) (Option), Arsanis shall pay to Adimab a non-creditable, nonrefundable option exercise fee of [**] dollars ($[**]) (the “Option Fee”).
Appears in 4 contracts
Sources: Option and License Agreement, Option and License Agreement (Arsanis, Inc.), Option and License Agreement (Arsanis, Inc.)